Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

CRT, University of Manchester and AstraZeneca work together to seek new cancer drugs

CANCER RESEARCH TECHNOLOGY, the commercial arm of Cancer Research UK, the University of Manchester and AstraZeneca today announced two agreements to seek new cancer drugs...

'Treatment alliance' needed to save more children's lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

Trial drug 'effective' against cancers with faulty BRAF gene

An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

Cancer Research Technology, The ICR and ZoBio BV sign deal to develop cancer drugs

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs...

Experimental drug may work in many cancers

Scientists have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have...

Glowing cells guide ovarian cancer surgery

Dutch surgeons have performed the first ever surgical procedures on ovarian cancer patients using new technology that illuminates ovarian cancer cells, making it easier to...

Cancer Research UK and CRT sign deal with Centella Therapeutics, inc to launch clinical development of radiotherapy-enhancing drug

Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm, have partnered with Centella Therapeutics, Inc. of Palo Alto,...

Gene could predict breast cancer patients' response to tamoxifen

Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen.

Faulty enzyme linked to certain brain tumours

US scientists have discovered that a faulty enzyme may contribute to the formation of some malignant brain tumours.

Gene could be important drug target for children's brain tumour

Scientists have discovered a gene that could lead to more effective treatments for a form of childhood brain cancer called paediatric high grade glioma

Pages